小米(01810.HK)否認將結束與Leica合作關係
對於市傳小米(01810.HK)即將結束與Leica的合作關係,小米公關部總經理王化直斥是胡說。
報道引述消息指出,小米專注於爲下一代驍龍8 Elite 2設備開發自主研發的相機技術,終止與Leica的合作,以降低生產成本及增強定價優勢,因Leica的授權費用每部手機能高達3至5美元。有關策略將波及小米的主要產品線,尤其是紅米和POCO系列。
據悉,小米與Leica於2022年正式開啓移動影像領域的戰略合作。目前,雙方已推出多個系列的聯名產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.